AccessDX Acquires 2bPrecise from Allscripts for Actionable Precision Medicine Insights

AccessDX Acquires 2bPrecise from Allscripts for Actionable Precision Medicine Insights

What You Should Know:

AccessDX, a leading diagnostic laboratory, and diagnostic technology company has acquired 2bPrecise, a genomic and healthcare informatics innovator, from Allscripts Healthcare Solutions. This merger comes as advances in genetic research and medicine have driven skyrocketing demand for genetic testing, data, and insights by healthcare providers, laboratories, and consumers around the world. Financial details of the acquisition were not disclosed.

– Hospitals, health systems, and practices are clamoring for access to genetic testing and the informatic insights and workflows required to make practical use of that data in patient care. Together, 2bPrecise and AccessDX will offer a complete solution to drive the next generation of precision medicine, making data and insights easily accessible and usable across the healthcare continuum.

– The combination will create the most advanced and complete precision medicine solution available in the market today and will help drive broad adoption across a wide range of specialties. AccessDX offers a comprehensive set of diagnostic services and technology solutions. 2bPrecise takes genetic testing data and delivers point-of-care genetic insights within the EHR workflow. Together, they will give providers easy access to advanced genetic testing and enable them to quickly leverage that data to identify patients at risk for heritable conditions and drug-gene interactions, empowering them to make more precise diagnoses, and identify the most optimal therapies.